XD
XDNA.TO iShares Genomics Immunology and Healthcare Index ETF CAD
- CAD
No recent price
- Total assets
- 17.4M
- Expense ratio
- -
- Dividend yield
- 0.19%
- 1-year return
- +75.65%
- Holdings
- 10
- Since
- 2022
Fund data as reported by the issuer, updated Nov 11, 2026. Total assets are in the fund's base currency.
What does XDNA.TO invest in?
Tracks Morningstar Gbl Health GR CAD- Mostly US Equity (69.4%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (67.7%)
- Top 3 holdings: 25.9% of the fund
Asset allocation
- US Equity 69.4%
- Equity 2.3%
- Cash 0.2%
Top holdings
- Moderna Inc 12.91%
- Genmab A/S 6.65%
- Twist Bioscience Corp 6.33%
- Regeneron Pharmaceuticals Inc 3.81%
- Takeda Pharmaceutical Co. Ltd. 3.78%
iShares Genomics Immunology and Healthcare Index ETF CAD performance
Sharpe ratio 1.27- This year
- +70.94%
- 1 year
- +75.65%
- 3 years
- +36.85%
- 5 years
- 0.00%
Volatility 28.3% over 1 year and 23.9% over 3 years. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
XDNA.TO price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
iShares Genomics Immunology and Healthcare Index ETF CAD top holdings
51.3% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Moderna Inc MRNA.US | Healthcare | United States | 12.91% |
| Genmab A/S GMAB.CO | Healthcare | Denmark | 6.65% |
| Twist Bioscience Corp TWST.US | Healthcare | United States | 6.33% |
| Regeneron Pharmaceuticals Inc REGN.US | Healthcare | United States | 3.81% |
| Takeda Pharmaceutical Co. Ltd. 4502.TSE | Healthcare | Japan | 3.78% |
| Bayer AG NA BAYN.XETRA | Healthcare | Germany | 3.68% |
| Caris Life Sciences, Inc. Common Stock CAI.US | Healthcare | United States | 3.66% |
| Exelixis Inc EXEL.US | Healthcare | United States | 3.59% |
| Revolution Medicines Inc RVMD.US | Healthcare | United States | 3.57% |
| Vertex Pharmaceuticals Inc VRTX.US | Healthcare | United States | 3.29% |
XDNA.TO sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
XDNA.TO regional exposure
- North America67.7%
- Europe Developed20.4%
- Japan5.8%
- United Kingdom2.8%
- Asia Emerging1.6%
- Asia Developed0.2%
Share of the stocks in the fund.
Company size
Average market cap 32.6B- Mega cap13.3%
- Big cap20.8%
- Medium cap31.5%
- Small cap12.6%
- Micro cap18.9%
iShares Genomics Immunology and Healthcare Index ETF CAD fund profile
- Fund name
- iShares Genomics Immunology and Healthcare Index ETF CAD
- Ticker
- XDNA.TO
- Exchange
- Toronto Exchange
- Index tracked
- Morningstar Gbl Health GR CAD
- Category
- Healthcare Equity
- Domicile
- Canada
- Inception date
- Apr 26, 2022
- Trading currency
- CAD
- Expense ratio
- -
- Dividends paid
- Annually
- Annual turnover
- 0.6%